menu
    • menu

    Company profile for Kamada

    NEW Drugs in Dev: 13
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Guizhou Utide Biotechnology Co., Ltd. - Specialized GMP manufacturing for next-generation GLP-1 peptide APIs.

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Kamada Ltd. is focused on plasma-derived protein therapeutics for orphan indications, and has a commercial product portfolio and a robust late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins. AAT i...
    Kamada Ltd. is focused on plasma-derived protein therapeutics for orphan indications, and has a commercial product portfolio and a robust late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins. AAT is a protein derived from human plasma with known and newly-discovered therapeutic roles given its immunomodulatory, anti-inflammatory, tissue-protective and antimicrobial properties.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    KamadaIsrael Flag
    Country
    Country
    Israel
    Address
    Address
    HEAD OFFICE 2 Holzman St, Science Park, P.O Box 4081, Rehovot 7670402, Israel
    Telephone
    Telephone
    +972 8 9406472
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.kamada.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/117855
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    PBP World Meeting

    Not Confirmed

    envelop Contact Supplier

    PBP World Meeting

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Kamada Announces $0.25 Per Share Cash Dividend Policy
    Kamada Announces $0.25 Per Share Cash Dividend Policy

    11 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/11/3253633/0/en/Kamada-Declares-Cash-Dividend-of-0-25-Per-Share-to-be-Paid-in-Accordance-with-an-Adopted-Annual-Cash-Dividend-Policy.html

    GLOBENEWSWIRE
    11 Mar 2026
    Share Share
    Kamada Records Strong 2025 Financials, Confirms 2026 Growth Plan
    Kamada Records Strong 2025 Financials, Confirms 2026 Growth Plan

    11 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/11/3253639/0/en/Kamada-Reports-Record-Top-and-Bottom-line-2025-Financial-Results-and-Affirms-2026-Guidance-Representing-Continued-Double-Digit-Organic-Profitable-Growth.html

    GLOBENEWSWIRE
    11 Mar 2026
    Share Share
    Kamada To Report Fy And Q4 2025 Financials On March 11, 2026
    Kamada To Report Fy And Q4 2025 Financials On March 11, 2026

    04 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/04/3249219/0/en/Kamada-to-Announce-Fiscal-Year-and-Fourth-Quarter-2025-Financial-Results-on-March-11-2026.html

    GLOBENEWSWIRE
    04 Mar 2026
    Share Share
    Kamada Forecasts Double-Digit Revenue Growth For 2026
    Kamada Forecasts Double-Digit Revenue Growth For 2026

    07 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/07/3214400/0/en/Kamada-Provides-2026-Annual-Guidance-of-200-205-Million-in-Revenues-and-50-53-Million-of-Adjusted-EBITDA-Representing-Double-Digit-Growth-and-Affirms-2025-Financial-Guidance.html

    GLOBENEWSWIRE
    07 Jan 2026
    Share Share
    Kamada Extends Canadian Supply Tender By $10-$14M
    Kamada Extends Canadian Supply Tender By $10-$14M

    18 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/18/3207562/0/en/Kamada-Announces-a-10-14-Million-Extension-of-Canadian-Supply-Tender.html

    GLOBENEWSWIRE
    18 Dec 2025
    Share Share
    Kamada Halts Phase 3 Inhaled AAT Trial, Retains 2025 Guidance
    Kamada Halts Phase 3 Inhaled AAT Trial, Retains 2025 Guidance

    08 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/08/3201409/0/en/Kamada-Announces-Discontinuation-of-its-Phase-3-Inhaled-AAT-Clinical-Trial-Reiterates-2025-Full-Year-Guidance-and-Projects-Double-Digit-Growth-in-Revenues-and-Profitability-in-2026.html

    GLOBENEWSWIRE
    08 Dec 2025
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search